The significance of the co-existence of osteopontin and tumor-associated macrophages in gastric cancer progression

被引:71
|
作者
Lin, Chang-Ni [1 ]
Wang, Chih-Jung [2 ,3 ]
Chao, Ying-Jui [2 ,3 ]
Lai, Ming-Derg [1 ]
Shan, Yan-Shen [2 ,3 ]
机构
[1] Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci, Tainan 70101, Taiwan
[2] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Coll Med, Dept Surg, Tainan 70101, Taiwan
[3] Natl Cheng Kung Univ, Coll Med, Inst Clin Med, Tainan 70101, Taiwan
来源
BMC CANCER | 2015年 / 15卷
关键词
Gastric cancer; Osteopontin; Tumor-associated macrophage; Biomarker; Cancer immunology; BREAST-CANCER; INFILTRATING MACROPHAGES; HEPATOCELLULAR-CARCINOMA; CLINICAL-IMPLICATIONS; PANCREATIC-CANCER; IN-VIVO; METASTASIS; EXPRESSION; SURVIVAL; INVASION;
D O I
10.1186/s12885-015-1114-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Osteopontin (OPN) can recruit macrophages to the site of inflammation and promote tumorigenesis. M2 tumor-associated macrophages (M2-TAMs) also play an important role in cancer progression. This study aimed to clarify the role of OPN and M2-TAMs co-existence in gastric cancer. Methods: The levels of OPN and M2-TAMs were evaluated by immunohistochemical staining in 170 resected gastric cancer specimens that were collected from 1998 to 2012. M2-TAMs were identified by staining for an M2 marker, CD204. The prognostic significance and correlation between OPN and CD204 expression were analyzed. A co-culture system of OPN+-AGS and U937 cells was designed to study the effect of OPN on the skewing of macrophages toward M2-TAMs for gastric cancer progression in vitro and in vivo. Results: Patients with high expression (>50%) of OPN or CD204 exhibited poor 5-year overall survival rates (48.61%, p = 0.0055, and 52.14%, p = 0.0498, respectively). A positive correlation was observed between OPN and CD204 expression and high co-expression of OPN and CD204 demonstrated poor 5-year overall survival rates (48.90%, p = 0.0131). In the co-culture study, OPN was able to attract U937 cells and skew them toward M2-TAMs through paracrine action. The M2-TAMs could increase the invasiveness of OPN+-AGS cells and the growth rate of xenograft of a mixture of co-cultured OPN+-AGS and U937 cells. Conclusion: OPN can skew macrophages toward M2-TAMs during gastric cancer progression. The co-existence of OPN and infiltrating M2-TAMs correlates with disease progression and poor survival and thus can serve as a prognostic marker in gastric cancer.
引用
收藏
页数:10
相关论文
共 50 条
  • [21] Surfactant Protein A Suppresses Lung Cancer Progression by Regulating the Polarization of Tumor-Associated Macrophages
    Mitsuhashi, Atsushi
    Goto, Hisatsugu
    Kuramoto, Takuya
    Tabata, Sho
    Yukishige, Sawaka
    Abe, Shinji
    Hanibuchi, Masaki
    Kakiuchi, Soji
    Saijo, Atsuro
    Aono, Yoshinori
    Uehara, Hisanori
    Yano, Seiji
    Ledford, Julie G.
    Sone, Saburo
    Nishioka, Yasuhiko
    AMERICAN JOURNAL OF PATHOLOGY, 2013, 182 (05) : 1843 - 1853
  • [22] Tumor-associated macrophages of the M2 phenotype contribute to progression in gastric cancer with peritoneal dissemination
    Takahisa Yamaguchi
    Sachio Fushida
    Yasuhiko Yamamoto
    Tomoya Tsukada
    Jun Kinoshita
    Katsunobu Oyama
    Tomoharu Miyashita
    Hidehiro Tajima
    Itasu Ninomiya
    Seiichi Munesue
    Ai Harashima
    Shinichi Harada
    Hiroshi Yamamoto
    Tetsuo Ohta
    Gastric Cancer, 2016, 19 : 1052 - 1065
  • [23] Role of Biological Mediators of Tumor-Associated Macrophages in Breast Cancer Progression
    Li, Yan
    Ganesan, Kumar
    Chen, Jianping
    CURRENT MEDICINAL CHEMISTRY, 2022, 29 (33) : 5420 - 5440
  • [24] Prognostic significance of tumor-associated macrophages in breast cancer: a meta-analysis of the literature
    Zhao, Xixi
    Qu, Jingkun
    Sun, Yuchen
    Wang, Jizhao
    Liu, Xu
    Wang, Feidi
    Zhang, Hong
    Wang, Wen
    Ma, Xingcong
    Gao, Xiaoyan
    Zhang, Shuqun
    ONCOTARGET, 2017, 8 (18) : 30576 - 30586
  • [25] The Two Faces of Tumor-Associated Macrophages and Their Clinical Significance in Colorectal Cancer
    Pinto, Marta L.
    Rios, Elisabete
    Doraes, Cecilia
    Ribeiro, Ricardo
    Machado, Jose C.
    Mantovani, Alberto
    Barbosa, Mario A.
    Carneiro, Fatima
    Oliveira, Maria J.
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [26] Reprogramming tumor-associated macrophages in gastric cancer: a pathway to enhanced immunotherapy
    He, Yibo
    Hong, Qianran
    Chen, Shiliang
    Zhou, Jiayi
    Qiu, Shengliang
    FRONTIERS IN IMMUNOLOGY, 2025, 16
  • [27] Prognostic significance of combined Lymphocyte-monocyte Ratio and Tumor-associated Macrophages in Gastric Cancer Patients after Radical Resection
    Xu, Bin-bin
    Xu, Yu
    Lu, Jun
    Wu, Yuan
    Wang, Jia-bin
    Lin, Jian-xian
    Xie, Jian-wei
    Li, Ping
    Zheng, Chao-hui
    Huang, Ai-min
    Huang, Chang-ming
    JOURNAL OF CANCER, 2020, 11 (17): : 5078 - 5087
  • [28] Tumor-associated macrophages: Potential therapeutic targets and diagnostic markers in cancer
    Song, Junyang
    Xiao, Tian
    Li, Mingyang
    Jia, Qingge
    PATHOLOGY RESEARCH AND PRACTICE, 2023, 249
  • [29] Targeting tumor-associated macrophages to combat pancreatic cancer
    Cui, Ran
    Yue, Wen
    Lattime, Edmund C.
    Stein, Mark N.
    Xu, Qing
    Tan, Xiang-Lin
    ONCOTARGET, 2016, 7 (31) : 50735 - 50754
  • [30] Harnessing tumor-associated macrophages as aids for cancer immunotherapy
    Li, Xiaolei
    Liu, Rui
    Su, Xiao
    Pan, Yongsha
    Han, Xiaofeng
    Shao, Changshun
    Shi, Yufang
    MOLECULAR CANCER, 2019, 18 (01)